XXI Wealth LLC’s Cardinal Health CAH Stock Holding History

XXI Wealth LLC’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$889K	Buy	3,742 +178	+5%	+$37K	0.41%	63
2026 Q1	$753K	Buy	3,564 +26	+0.7%	+$5.6K	0.43%	65
2025 Q4	$727K	Buy	+3,538	New	+$666K	0.44%	60

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

XXI Wealth LLC's CAH Position: Q2 2026 in Review

XXI Wealth LLC increased its Cardinal Health (CAH) stake by 5% in Q2 2026, buying an estimated $37K and bringing the position to 3,742 shares worth $889K. The position accounts for 0.41% of the portfolio, ranked #63.

XXI Wealth LLC first reported a position in CAH in Q4 2025 and has held it in 3 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

XXI Wealth LLC held 3,742 shares of Cardinal Health worth $889K as of Q2 2026.
XXI Wealth LLC bought 178 Cardinal Health shares in Q2 2026, an estimated $37K.
Cardinal Health made up 0.41% of XXI Wealth LLC's portfolio in Q2 2026, its #63 holding.
XXI Wealth LLC first reported a position in Cardinal Health in Q4 2025 and has held it in 3 quarters since.
1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on XXI Wealth LLC's 13F filing for Q2 2026, filed 14 Aug 2026.